180 related articles for article (PubMed ID: 28147311)
1. SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.
Song G; Liu K; Yang X; Mu B; Yang J; He L; Hu X; Li Q; Zhao Y; Cai X; Feng G
Oncotarget; 2017 Mar; 8(11):17771-17784. PubMed ID: 28147311
[TBL] [Abstract][Full Text] [Related]
2. [SATB1 promotes the malignant of human non-Hodgkin lymphoma by activating the ribonucleotide reductase
small subunit M2].
Yan D; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1155-1162. PubMed ID: 27932760
[TBL] [Abstract][Full Text] [Related]
3. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
[TBL] [Abstract][Full Text] [Related]
4. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.
Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z
Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419
[TBL] [Abstract][Full Text] [Related]
5. Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion.
Aktary Z; Pasdar M
PLoS One; 2013; 8(11):e78388. PubMed ID: 24260116
[TBL] [Abstract][Full Text] [Related]
6. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.
Shukla S; Sharma H; Abbas A; MacLennan GT; Fu P; Danielpour D; Gupta S
PLoS One; 2013; 8(1):e53527. PubMed ID: 23308245
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of SATB1 increases the invasiveness of Jurkat cell via activation of the WNT/β-catenin signaling pathway in vitro.
Luo XD; Yang SJ; Wang JN; Tan L; Liu D; Wang YY; Zheng RH; Wu XH; Xu LH; Tan H
Tumour Biol; 2016 Jun; 37(6):7413-9. PubMed ID: 26678884
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
[TBL] [Abstract][Full Text] [Related]
10. SATB1 is a Novel Molecular Target for Cancer Therapy.
Ding M; Pan J; Guo Z; Liu Q; Yang C; Mao L
Cancer Invest; 2018 Jan; 36(1):28-36. PubMed ID: 29381393
[TBL] [Abstract][Full Text] [Related]
11. Functional relevance of SATB1 in immune regulation and tumorigenesis.
Sunkara KP; Gupta G; Hansbro PM; Dua K; Bebawy M
Biomed Pharmacother; 2018 Aug; 104():87-93. PubMed ID: 29772444
[TBL] [Abstract][Full Text] [Related]
12. The Special AT-rich Sequence Binding Protein 1 (SATB1) and its role in solid tumors.
Frömberg A; Engeland K; Aigner A
Cancer Lett; 2018 Mar; 417():96-111. PubMed ID: 29306014
[TBL] [Abstract][Full Text] [Related]
13. SATB1 and bladder cancer: Is there a functional link?
Choudhary D; Clement JM; Choudhary S; Voznesensky O; Pilbeam CC; Woolbright BL; Taylor JA
Urol Oncol; 2018 Mar; 36(3):93.e13-93.e21. PubMed ID: 29079132
[TBL] [Abstract][Full Text] [Related]
14. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression.
Kuo IY; Wu CC; Chang JM; Huang YL; Lin CH; Yan JJ; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Cancer; 2014 Aug; 135(3):563-73. PubMed ID: 24407731
[TBL] [Abstract][Full Text] [Related]
15. SATB1 promotes tumor metastasis and invasiveness in oral squamous cell carcinoma.
Li YC; Bu LL; Mao L; Ma SR; Liu JF; Yu GT; Deng WW; Zhang WF; Sun ZJ
Oral Dis; 2017 Mar; 23(2):247-254. PubMed ID: 27783844
[TBL] [Abstract][Full Text] [Related]
16. Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma.
Frömberg A; Rabe M; Aigner A
Int J Cancer; 2014 Dec; 135(11):2537-46. PubMed ID: 24729451
[TBL] [Abstract][Full Text] [Related]
17. Decoy-DNA against special AT-rich sequence binding protein 1 inhibits the growth and invasive ability of human breast cancer.
Yamayoshi A; Yasuhara M; Galande S; Kobori A; Murakami A
Oligonucleotides; 2011; 21(2):115-21. PubMed ID: 21500976
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of long noncoding RNA UCA1 by SATB1 in breast cancer.
Lee JJ; Kim M; Kim HP
BMB Rep; 2016 Oct; 49(10):578-583. PubMed ID: 27697109
[TBL] [Abstract][Full Text] [Related]
19. Fluvastatin-mediated down-regulation of SATB1 affects aggressive phenotypes of human non-small-cell lung cancer cell line H292.
Xu HY; Xue JX; Gao H; Na FF; Li H; Zhang T; Lu Y
Life Sci; 2019 Apr; 222():212-220. PubMed ID: 30557545
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
Frömberg A; Rabe M; Oppermann H; Gaunitz F; Aigner A
BMC Cancer; 2017 Jan; 17(1):3. PubMed ID: 28049521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]